Inicia sesión Registrate Mi Biblioteca biblioteca abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de artículos sobre la enfermedad de Alzheimer/demencias y sobre los Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.

164142 ARTíCULOS , VIENDO DEL 163786 AL 163800

PUBMED

Associations between Brain Structural Damage and Core Muscle Loss in Patients with Parkinson's Disease

Wu YN, Chen MH, Chiang PL, Lu CH, Chen HL, Yu CC, Chen YS, Chang YY, Lin WC.

J Clin Med. 2020 Jan 16;9(1):239. doi: 10.3390/jcm9010239.

0

0

0

PUBMED

General Anesthesia versus Local Anesthesia for Deep Brain Stimulation in Parkinson's Disease: A Meta-Analysis.

Liu Z, He S, Li L.

Stereotact Funct Neurosurg. 2020 Jan 21:1-10. doi: 10.1159/000505079. [Epub ahead of print] Review.

0

0

0

PUBMED

Variations in rest-activity rhythm are associated with clinically measured disease severity in Parkinson's disease

Brooks C, Shaafi Kabiri N, Mortazavi F, Auerbach S, Bonato P, Erb MK, Czech M, Karlin D, Rolph T, Bhangu J, Thomas K.

Chronobiol Int. 2020 Jan 21:1-13. doi: 10.1080/07420528.2020.1715998. Online ahead of print.

0

0

0

PUBMED

Characterization of a Parkinson's disease rat model using an upgraded paraquat exposure paradigm

Cristóvão AC, Campos FL, Je G, Esteves M, Guhathakurta S, Yang L, Beal MF, Fonseca BM, Salgado AJ, Queiroz J, Sousa N, Bernardino L, Alves G, Yoon KS, Kim YS.

Eur J Neurosci. 2020 Jan 20. doi: 10.1111/ejn.14683. Online ahead of print.

0

0

0

PUBMED

Penetrance of Parkinson's Disease in LRRK2 p.G2019S Carriers Is Modified by a Polygenic Risk Score

Iwaki H, Blauwendraat C, Makarious MB, Bandrés-Ciga S, Leonard HL, Gibbs JR, Hernandez DG, Scholz SW, Faghri F; International Parkinson's Disease Genomics Consortium (IPDGC), Nalls MA, Singleton AB.

Mov Disord. 2020 May;35(5):774-780. doi: 10.1002/mds.27974. Epub 2020 Jan 20.

0

0

0

PUBMED

Does Developmental Variability in the Number of Midbrain Dopamine Neurons Affect Individual Risk for Sporadic Parkinson's Disease?

von Linstow CU, DeLano-Taylor M, Kordower JH, Brundin P.

J Parkinsons Dis. 2020;10(2):405-411. doi: 10.3233/JPD-191877.

0

0

0

PUBMED

Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person

Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, Kwok K, Cannon P, Marek K,

J Parkinsons Dis. 2020;10(2):677-691. doi: 10.3233/JPD-191808.

0

0

0

PUBMED

The Novel Dual GLP-1/GIP Receptor Agonist DA-CH5 Is Superior to Single GLP-1 Receptor Agonists in the MPTP Model of Parkinson's Disease

Zhang L, Zhang L, Li Y, Li L, Melchiorsen JU, Rosenkilde M, Hölscher C.

J Parkinsons Dis. 2020;10(2):523-542. doi: 10.3233/JPD-191768.

0

0

0

PUBMED

Supplementary management with Pycnogenol® in Parkinson's disease to prevent cognitive impairment

Cesarone MR, Belcaro G, Hosoi M, Ledda A, Feragalli B, Maione C, Scipione C, Scipione V, Cotellese R, Hu S.

J Neurosurg Sci. 2020 Jun;64(3):258-262. doi: 10.23736/S0390-5616.19.04839-2. Epub 2020 Jan 20.

0

0

0

PUBMED

Comparing GPS-Based Community Mobility Measures with Self-report Assessments in Older Adults with Parkinson's Disease

Zhu L, Duval C, Boissy P, Montero-Odasso M, Zou G, Jog M, Speechley M.

J Gerontol A Biol Sci Med Sci. 2020 Nov 13;75(12):2361-2370. doi: 10.1093/gerona/glaa012.

0

0

0

PUBMED

State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson's disease

Quarracino C, Otero-Losada M, Capani F, Pérez-Lloret S.

Expert Opin Pharmacother. 2020 Mar;21(4):445-457. doi: 10.1080/14656566.2020.1713097. Epub 2020 Jan 20.

0

0

0

PUBMED

Longitudinal volume changes of hippocampal subfields and cognitive decline in Parkinson's disease

Xu R, Hu X, Jiang X, Zhang Y, Wang J, Zeng X.

Quant Imaging Med Surg. 2020 Jan;10(1):220-232. doi: 10.21037/qims.2019.10.17.

0

0

0

PUBMED

Dysbiosis in Parkinson's disease might be triggered by certain antibiotics

Ternák G, Kuti D, Kovács KJ.

Med Hypotheses. 2020 Apr;137:109564. doi: 10.1016/j.mehy.2020.109564. Epub 2020 Jan 9.

0

0

0

PUBMED

Therapeutic effects of forced exercise cycling in individuals with Parkinson's disease

Miner DG, Aron A, DiSalvo E.

J Neurol Sci. 2020 Mar 15;410:116677. doi: 10.1016/j.jns.2020.116677. Epub 2020 Jan 9.

0

0

0

PUBMED

Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene

Azevedo C, Chumarina M, Serafimova E, Goldwurm S, Collin A, Roybon L, Savchenko E, Pomeshchik Y.

Stem Cell Res. 2020 Mar;43:101694. doi: 10.1016/j.scr.2019.101694. Epub 2020 Jan 11.

0

0

0

Comentarios

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neuroacademy